Damora Therapeutics, Inc.
DMRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001800315
In the last 90 days, Damora Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 104 institutions reported holding it in 13F filings for Q2 2026, worth $1.67B in total; Viking Global Investors is the only superinvestor holding it.
Holders of 5% or more of DMRA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Damora Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Fairmount Funds Management LLC | 13D/A | 19.99%8.71M shares | 0.00 ppfrom 19.99% | Nov 17, 20252 filings | Feb 11, 2026 | SEC |
| FMR LLC | 13G | 15.00%238.9K shares | New | Dec 5, 20251 filing | Dec 5, 2025 | SEC |
| Otto Erik | 13G/A | 7.60%2.06M shares | – | Feb 9, 20241 filing | Feb 9, 2024 | SEC |
| Jain Global LLC | 13G | 7.50%120.6K shares | New | Feb 17, 20261 filing | Feb 17, 2026 | SEC |
| Paramora Holding LLC | 13G | 7.50%120.5K shares | New | Jan 12, 20261 filing | Jan 12, 2026 | SEC |
| Paragon Therapeutics, Inc. | 13G | 7.50%120.5K shares | New | Jan 12, 20261 filing | Jan 12, 2026 | SEC |
| Point72 Asset Management, L.P. | 13G | 6.30%100.0K shares | New | Nov 13, 20251 filing | Nov 13, 2025 | SEC |
| Venrock Healthcare Capital Partners III, L.P. | 13G | 6.00%3.60M shares | New | Feb 17, 20261 filing | Feb 17, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
14 Schedule 13D and 13G filings on Damora Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 6, 20264:43 PM ET | Ikarian Capital, LLCand 1 other | 13G/A | 0.60%335.7K shares | −20.90 ppfrom 21.50%Below 5% | Feb 28, 2026 | SEC |
| Feb 17, 20267:17 PM ET | Venrock Healthcare Capital Partners III, L.P.and 6 others | 13G | 6.00%3.60M shares | New | Feb 9, 2026 | SEC |
| Feb 17, 20264:35 PM ET | Jain Global LLCand 2 others | 13G | 7.50%120.6K shares | New | Dec 31, 2025 | SEC |
| Feb 11, 20266:11 PM ET | Fairmount Funds Management LLCand 4 others | 13D/A | 19.99%8.71M shares | 0.00 ppfrom 19.99% | Feb 9, 2026 | SEC |
| Jan 12, 20264:06 PM ET | Paramora Holding LLC | 13G | 7.50%120.5K shares | New | Nov 10, 2025 | SEC |
| Jan 12, 20264:01 PM ET | Paragon Therapeutics, Inc. | 13G | 7.50%120.5K shares | New | Nov 10, 2025 | SEC |
| Dec 5, 20254:50 PM ET | Ikarian Capital, LLCand 1 other | 13G | 21.50%285.7K shares | New | Nov 30, 2025 | SEC |
| Dec 5, 20251:50 PM ET | FMR LLCand 1 other | 13G | 15.00%238.9K shares | New | Nov 28, 2025 | SEC |
| Nov 17, 20259:45 PM ET | Fairmount Funds Management LLCand 4 others | 13D | 19.99%397.0K shares | New | Nov 10, 2025 | SEC |
| Nov 13, 20255:26 PM ET | Point72 Asset Management, L.P.and 2 others | 13G | 6.30%100.0K shares | New | Nov 12, 2025 | SEC |
| Oct 9, 20254:29 PM ET | Novo Holdings A/S | 13D/A | 0.00%0 shares | −6.50 ppfrom 6.50%Below 5% | Oct 7, 2025 | SEC |
| Sep 25, 20254:49 PM ET | Novo Holdings A/S | 13D/A | 6.50%86.6K shares | −1.10 ppfrom 7.60% | Sep 23, 2025 | SEC |
| Jan 16, 20259:43 PM ET | Novo Holdings A/S | 13D/A | 7.60%99.9K shares | – | Aug 29, 2024 | SEC |
| Feb 9, 20243:06 PM ET | Otto Erik | 13G/A | 7.60%2.06M shares | – | Dec 31, 2023 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Damora Therapeutics, Inc. shares.
No Form 144 notices for Damora Therapeutics, Inc. are on file.